SERB Pharmaceuticals Acquires RSDL Kit from Emergent BioSolutions for $75M

CURE Pharmaceutical to Acquire Sera Labs for $20 Million

July 30, 2020

Consumer Products

CURE Pharmaceutical entered a memorandum of understanding to acquire 100% of privately held Sera Labs for $20 million in a deal composed primarily of CURE stock, with potential earn-outs of up to an additional $20 million. The acquisition adds Sera Labs' CBD-focused branded portfolio, DTC subscription model and retail/wholesale distribution (over 8,850 U.S. doors) to CURE's cGMP manufacturing and drug-delivery capabilities, with Sera Labs founder Nancy Duitch remaining in a leadership role.

StatLab Medical Products Acquires Scientific Device Laboratory

April 25, 2024

Medical Devices

StatLab Medical Products, a McKinney, Texas-based manufacturer of medical diagnostic supplies, has acquired Scientific Device Laboratory (SDL), a Chicago-area maker of printed diagnostic slides and consumables for anatomic pathology and microbiology. The acquisition expands StatLab's microbiology capabilities, adds a U.S. R&D/manufacturing hub, and creates a dual-continent footprint for glass-slide manufacturing to better serve hospital, OEM and research customers.

SERB Pharmaceuticals Acquires Y-mAbs Therapeutics

September 16, 2025

Biotechnology

SERB Pharmaceuticals completed its acquisition of Y-mAbs Therapeutics following a tender offer and statutory merger, making Y-mAbs a wholly owned subsidiary and delisting it from Nasdaq. The deal adds Y-mAbs' antibody-based oncology assets — including Danyelza (naxitamab-gqgk) — to SERB's rare disease and rare oncology portfolio to expand its commercial capabilities in pediatric and rare cancers.

Laboratoires SERB (Charterhouse-backed) to acquire BTG Specialty Pharmaceuticals from Boston Scientific

December 1, 2020

Pharmaceuticals

Charterhouse Capital Partners–backed Laboratoires SERB has agreed to acquire BTG Specialty Pharmaceuticals from Boston Scientific. The deal expands SERB’s portfolio of emergency and critical‑care medicines (including CroFab, DigiFab and Voraxaze), strengthening its manufacturing capabilities and global commercial reach.

Mitsui & Co. Acquires Dermaceutical Laboratories (D-LAB)

August 21, 2023

Consumer Products

Mitsui & Co., Ltd. has agreed to acquire all shares of Dermaceutical Laboratories, LLC (D-LAB), a Bergen County, New Jersey-based cosmetics ODM and contract manufacturer. Mitsui will position D-LAB as the core beauty & personal care (BPC) business in the Americas, leveraging Japanese technologies and Mitsui's procurement and global network to expand capabilities and scale in the U.S. market.

DermBiont Acquires SeylanMED to Expand Dermatology Pipeline

October 21, 2020

Biotechnology

DermBiont, a Boston-based clinical-stage precision dermatology company, has acquired SeylanMED, adding a targeted topical AKT inhibitor gel candidate for seborrheic keratosis to its pipeline. The acquisition expands DermBiont's therapeutic modalities and accelerates its objective to develop targeted topical treatments and live bacterial therapeutics for skin diseases.